Risk score predicts high‐grade prostate cancer in DNA‐methylation positive, histopathologically negative biopsies

BACKGROUND: Prostate cancer (PCa) diagnosis is challenging because efforts for effective, timely treatment of men with significant cancer typically result in over‐diagnosis and repeat biopsies. The presence or absence of epigenetic aberrations, more specifically DNA‐methylation of GSTP1, RASSF1, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Neste, Leander, Partin, Alan W., Stewart, Grant D., Epstein, Jonathan I., Harrison, David J., Van Criekinge, Wim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5111760/
https://www.ncbi.nlm.nih.gov/pubmed/27121847
http://dx.doi.org/10.1002/pros.23191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5111760/
https://www.ncbi.nlm.nih.gov/pubmed/27121847
http://dx.doi.org/10.1002/pros.23191

Ejemplares similares